Results 191 to 200 of about 2,267,015 (325)

The Pharmacological Basis of Therapeutics: a Textbook of Pharmacology, Toxicology and Therapeutics for Physicians and Medical Students

, 1942
NULL AUTHOR_ID
openalex   +1 more source

An Address ON THE PRINCIPLES OF WOUND TREATMENT AS ESTABLISHED BY LISTER AND THE SUBSEQUENT MODIFICATIONS IN TREATMENT: Delivered to the Students' Medical Society, Aberdeen [PDF]

, 1914
Francis Caird
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Medical students' perception of paid E-learning. [PDF]

PLoS One
Mohri P, Koyluoglu YO, Seker ME, Sancak SN, Dikeç M, Mazlumoglu AA, Gurol Y, Sungur IC.   +7 more
europepmc   +1 more source

THE NEEDS OF LONDON MEDICAL STUDENTS. [PDF]

, 1908
Milliarium Aureum
openalex   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

How much do medical students know about cancer risk factors? [PDF]

BMC Med Educ
Keten HS, Dogan GG, Akbayram HT, Isik O.
europepmc   +1 more source

THE MEDICAL LIBRARY AND THE MEDICAL STUDENT.

Bulletin of the Medical Library Association, 1996
E C, Long, P G, Miller
openaire   +3 more sources

THE VALUE TO THE MEDICAL STUDENT OF PHYSIOLOGIC STUDY. [PDF]

, 1896
John Benson
openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source